Skip to main content
Veterinary Medicines

4XLA Post-Milking Germicidal Teat Dip Solution

Authorised
  • Lactic acid
  • Sodium chlorite

Product identification

Medicine name:
4XLA Post-Milking Germicidal Teat Dip Solution
Active substance:
  • Lactic acid
  • Sodium chlorite
Target species:
  • Cattle
Route of administration:
  • Topical use

Product details

Active substance and strength:
  • Lactic acid
    2.64
    gram(s)
    /
    100.00
    millilitre(s)
  • Sodium chlorite
    0.64
    gram(s)
    /
    100.00
    millilitre(s)
Pharmaceutical form:
  • Teat dip solution
Withdrawal period by route of administration:
  • Topical use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QG52A
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Package description:
  • HDPE containers, one each for base and activator, which fills 208 litres, sealed with HDPE screw on caps.
  • HDPE containers, one each for base and activator, which fills 56.8 litres, sealed with HDPE screw on caps.
  • HDPE containers, one each for base and activator, which fills 20 litres, sealed with HDPE screw on caps.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Ecolab Deutschland GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Ferdinand Eimermacher GmbH & Co. KG
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10795/002/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 8/04/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."